“抗体和免疫偶联物在癌症治疗中的应用”增刊简介。
Introduction to the supplement, "Cancer Therapy with Antibodies and Immunoconjugates".
出版信息
Cancer. 2010 Feb 15;116(4 Suppl):1011-2. doi: 10.1002/cncr.24786.
Abstract
This supplement includes 16 representative articles presented at the 12th Conference on Cancer Therapy With Antibodies and Immunconjugates, Parsippany, New Jersey, October 16-18, 2008, encompassing cancer treatment with unconjugated and isotope-conjugated antibodies targeting selective cancer biomarkers.
摘要
本增刊收录了在 2008 年 10 月 16 日至 18 日于新泽西州帕西帕尼举行的第 12 届癌症治疗用抗体和免疫偶联物会议上提交的 16 篇有代表性的文章，涵盖了针对选择性癌症生物标志物的未缀合和同位素缀合抗体的癌症治疗。
相似文献
1
Introduction to the supplement, "Cancer Therapy with Antibodies and Immunoconjugates".
Cancer. 2010 Feb 15;116(4 Suppl):1011-2. doi: 10.1002/cncr.24786.
2
Cancer therapy with antibodies and immunoconjugates. Proceedings of the 12th Conference on Cancer Therapy With Antibodies and Immunoconjugates. Parsippany, New Jersey, USA. October 16-18, 2008.
Cancer. 2010 Feb 15;116(4 Suppl):i-ii, 1011-145. doi: 10.1002/cncr.25001.
3
Abstracts from the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates. October 12-14, 2006. Parsippany, New Jersey, USA.
Cancer Biother Radiopharm. 2006 Aug;21(4):382-405. doi: 10.1089/cbr.2006.21.382.
4
Proceedings of the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates. October 12-14, 2006. Parsippany, New Jersey, USA.
Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5499s-660s.
5
[An overview of antibody therapy against cancer].
Nihon Rinsho. 2012 Dec;70(12):2087-92.
6
The use of monoclonal antibody immunoconjugates in cancer therapy.
Adv Exp Med Biol. 1994;353:169-79. doi: 10.1007/978-1-4615-2443-4_16.
7
Meeting report on the Ninth Conference on Cancer Therapy with Antibodies and Immunoconjugates.
Cancer Res. 2003 Nov 15;63(22):8069-71.
8
ImmunoGen Inc. Immunoconjugates in canacer therapy: if at first you don't succeed, try, try again.
Chem Biol. 2003 Sep;10(9):781-2. doi: 10.1016/j.chembiol.2003.09.005.
9
Antibodies as stratagems against cancer.
Mol Biosyst. 2016 Jun 21;12(7):2047-55. doi: 10.1039/c5mb00699f.
10
[An overview of antibody-based cancer therapy].
Yao Xue Xue Bao. 2012 Oct;47(10):1261-8.
本文引用的文献
1
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy.
Blood. 2009 Apr 23;113(17):3891-5. doi: 10.1182/blood-2008-11-188896. Epub 2009 Jan 30.
2
Novel radioimmunopharmaceuticals for cancer imaging and therapy.
Curr Opin Investig Drugs. 2008 Dec;9(12):1302-16.
3
Proceedings of the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates. October 12-14, 2006. Parsippany, New Jersey, USA.
Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5499s-660s.
4
Abstracts from the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates. October 12-14, 2006. Parsippany, New Jersey, USA.
Cancer Biother Radiopharm. 2006 Aug;21(4):382-405. doi: 10.1089/cbr.2006.21.382.
5
Targeted therapy of cancer: new prospects for antibodies and immunoconjugates.
CA Cancer J Clin. 2006 Jul-Aug;56(4):226-43. doi: 10.3322/canjclin.56.4.226.
6
Advances in radioimmunotherapy in the age of molecular engineering and pretargeting.
Cancer Invest. 2006 Feb;24(1):82-97. doi: 10.1080/07357900500449553.
Zotero 插件